Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Jacobs

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cancer Chemotherapy and Pharmacology|August 22, 2016
Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidinesDidier Meulendijks, Linda M Henricks, André B P van Kuilenburg, et al.
Pediatric Transplantation|March 1, 2016
Pharmacokinetics and target attainment of mycophenolate in pediatric renal transplant patientsLisa C Martial, Bart A W Jacobs, Elisabeth A M Cornelissen, et al.
Molecular Genetics and Metabolism|February 9, 2023
Evidence for effect of l-serine, a novel therapy for GRIN2B-related neurodevelopmental disorderB den Hollander, A R J Veenvliet, M Rothuizen-Lindenschot, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 29, 2022
Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic reviewMartijn H van der Ree, Laura van Dussen, Noa Rosenberg, et al.
Pharmaceutical Research|October 11, 2023
Cortisol as Biomarker for CYP17-Inhibition is Associated with Therapy Outcome of Abiraterone AcetateMaaike A C Bruin, Ma Ida Mohmaed Ali, Merel van Nuland, et al.
British Journal of Clinical Pharmacology|July 27, 2018
Food-effect study on uracil and dihydrouracil plasma levels as marker for dihydropyrimidine dehydrogenase activity in human volunteersLinda M Henricks, Bart A W Jacobs, Didier Meulendijks, et al.
Contemporary Clinical Trials Communications|March 27, 2024
Corrigendum to "Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials" [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233]Bibiche den Hollander, Marieke Rothuizen-Lindenschot, Lisa Geertjens, et al.
Contemporary Clinical Trials Communications|December 25, 2023
Effectiveness of L-serine supplementation in children with a <i>GRIN2B</i> loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trialsBibiche den Hollander, Marieke Rothuizen-Lindenschot, Lisa Geertjens, et al.
British Journal of Cancer|April 21, 2017
Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicityDidier Meulendijks, Linda M Henricks, Bart A W Jacobs, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 6, 2024
Challenges in the identification and quantification of an unknown impurity in chenodeoxycholic acid drug substanceNatalja Bouwhuis, Yasmin Polak, Anneliene M Schimmel, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|August 22, 2016
Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidinesDidier Meulendijks, Linda M Henricks, André B P van Kuilenburg, et al.
Pediatric Transplantation|March 1, 2016
Pharmacokinetics and target attainment of mycophenolate in pediatric renal transplant patientsLisa C Martial, Bart A W Jacobs, Elisabeth A M Cornelissen, et al.
Molecular Genetics and Metabolism|February 9, 2023
Evidence for effect of l-serine, a novel therapy for GRIN2B-related neurodevelopmental disorderB den Hollander, A R J Veenvliet, M Rothuizen-Lindenschot, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 29, 2022
Effectiveness and safety of mexiletine in patients at risk for (recurrent) ventricular arrhythmias: a systematic reviewMartijn H van der Ree, Laura van Dussen, Noa Rosenberg, et al.
Pharmaceutical Research|October 11, 2023
Cortisol as Biomarker for CYP17-Inhibition is Associated with Therapy Outcome of Abiraterone AcetateMaaike A C Bruin, Ma Ida Mohmaed Ali, Merel van Nuland, et al.
British Journal of Clinical Pharmacology|July 27, 2018
Food-effect study on uracil and dihydrouracil plasma levels as marker for dihydropyrimidine dehydrogenase activity in human volunteersLinda M Henricks, Bart A W Jacobs, Didier Meulendijks, et al.
Contemporary Clinical Trials Communications|March 27, 2024
Corrigendum to "Effectiveness of L-serine supplementation in children with a GRIN2B loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trials" [Contemp. Clin. Trials Commun. 36 (2023)/ DOI: 10.1016/j.conctc.2023.101233]Bibiche den Hollander, Marieke Rothuizen-Lindenschot, Lisa Geertjens, et al.
Contemporary Clinical Trials Communications|December 25, 2023
Effectiveness of L-serine supplementation in children with a <i>GRIN2B</i> loss-of-function mutation: Rationale and protocol for single patient (n-of-1) multiple cross-over trialsBibiche den Hollander, Marieke Rothuizen-Lindenschot, Lisa Geertjens, et al.
British Journal of Cancer|April 21, 2017
Pretreatment serum uracil concentration as a predictor of severe and fatal fluoropyrimidine-associated toxicityDidier Meulendijks, Linda M Henricks, Bart A W Jacobs, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 6, 2024
Challenges in the identification and quantification of an unknown impurity in chenodeoxycholic acid drug substanceNatalja Bouwhuis, Yasmin Polak, Anneliene M Schimmel, et al.
Pageof 5